Crossmark

Brain metabolic changes and clinical response to superolateral medial forebrain bundle deep brain stimulation for treatment-resistant depression

Published Online: 2022-08-19

Published Print: 2022-11

Authors

Conner, Christopher R. http://orcid.org/0000-0003-0176-9025
Quevedo, Joao http://orcid.org/0000-0003-3114-6611
Soares, Jair C. http://orcid.org/0000-0002-5466-5628
Fenoy, Albert J. http://orcid.org/0000-0002-9554-9885
License Information

Text and Data Mining valid from 2022-08-19

Version of Record valid from 2022-08-19
More Information

Article History

Received: 27 April 2022

Revised: 15 July 2022

Accepted: 26 July 2022

First Online: 19 August 2022

Competing interests

: AJF serves as a consultant for Medtronic, Inc and receives grant support from the NIH/NINDS (1R01NS113893-01A1). JQ receives research support from the NIH/NIMH (1R21MH117636-01A1), the Faillace Department of Psychiatry and Behavioral Sciences, and LivaNova; has speaker bureau membership with Myriad Neuroscience, Janssen Pharmaceuticals, and Abbvie; is a consultant for Eurofarma; is stockholder at Instituto de Neurociencias Dr. Joao Quevedo; and receives copyrights from Artmed Editora, Artmed Panamericana, and Elsevier/Academic Press. JCS receives grant/research support from Bristol-Meyers Squibb, Forest Laboratories, Merck, and Elan Pharmaceuticals, and serves as a consultant for Pfizer, Abbot, and Astellas Pharma, Inc. CRC reported no biomedical financial interests or potential conflicts of interest.

Document is current